STOCK TITAN

Stoke Therapeutics: RTW reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Stoke Therapeutics, Inc. (STOK) is the issuer in an amended beneficial-ownership report by RTW Investments, LP and Roderick Wong, its Managing Partner and Chief Investment Officer. They report shared voting and dispositive power over 6,537,475 shares, representing 9.99%.

The reported amount assumes exercise of warrants for 913,950 shares; the warrants cannot be exercised to the extent doing so would cause beneficial ownership to exceed 9.99%. The reported percentage is based on 64,526,242 shares outstanding as of July 30, 2026, and assumes warrant exercise. RTW Master Fund Ltd. has the right to receive or direct dividends or sale proceeds from more than 5% of the shares.

Shares beneficially owned 6,537,475 shares Reported by RTW Investments, LP and Roderick Wong; amount assumes exercise of warrants for 913,950 shares
Ownership percentage 9.99% Reported for each reporting person
Shares issuable under warrants assumed exercised 913,950 shares Assumed in the reported beneficial-ownership amount
Shares outstanding 64,526,242 shares As of July 30, 2026; basis cited for the reported percentage, which assumes warrant exercise
beneficially owned regulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared voting power: 6,537,475 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power: 6,537,475 shares"
Warrants financial
"warrants held by the Reporting Persons to purchase 913,950 Shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many STOK shares does RTW Investments report beneficially owning?

RTW Investments, LP reports beneficial ownership of 6,537,475 shares, with shared voting and dispositive power. The reported amount assumes exercise of warrants for 913,950 shares.

What limit applies to the warrants reported for STOK?

The warrants cannot be exercised to the extent an exercise would cause the reporting persons to beneficially own more than 9.99% of the outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





86150R107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:11/16/2026
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 1 to the Reporting Persons' Schedule 13G filed with the SEC on February 12, 2021).

Keep reading